Who we are
Our mission is to drive discovery and solve challenges for our partners, enabling them to deliver cost-effective, differentiated and efficacious RNA therapeutics.
At etherna, we have the skills and technologies to provide our partners with top-notch support in their development & manufacturing needs to acquire nucleic acid-based therapeutics and vaccines. We have an expansive portfolio of intellectual property and know-how, particularly on customizable Lipid Nano Particles (cLNPs), supported by RNA chemistry and process technologies. With a careful balance in our skillset, state-of-the-art facilities and specialized equipment, we tackle complex challenges efficiently.
Targeted delivery supported by RNA chemistry & process technologies